Status:
COMPLETED
Predictors of Pulmonary Hypertension Risk in Premature Infants With Bronchopulmonary Dysplasia
Lead Sponsor:
Stanford University
Conditions:
Bronchopulmonary Dysplasia (BPD)
Hypertension, Pulmonary
Eligibility:
All Genders
Up to 30 years
Brief Summary
A lung condition called bronchopulmonary dysplasia (BPD) is a major cause of poor outcomes and death for premature infants. Infants with BPD are also at high risk for pulmonary hypertension (PH)-an im...
Detailed Description
This study aims to 1) investigate the incidence of PH among premature infants with BPD versus those without BPD and 2) investigate ET-1 levels in infants with BPD-associated PH versus those without BP...
Eligibility Criteria
Inclusion
- Premature Infants (\<30 weeks EGA)
Exclusion
- Major congenital malformations (cardiac, respiratory, gastrointestinal)
- congenital infection, and/or
- known genetic syndromes (i.e. trisomy 21)
Key Trial Info
Start Date :
July 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 10 2019
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01516398
Start Date
July 1 2011
End Date
March 10 2019
Last Update
September 29 2021
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
El Camino Hospital
Mountain View, California, United States, 94040
2
Lucile Packard Children's Hospital at Stanford
Palo Alto, California, United States, 94304